Skip to content
Search

Latest Stories

Fearful of 'disenfranchising' independent contractors, NPA calls for re-think on pharmacy representation vote scheduled for early next year

Fearful of disenfranchising the entire independent community pharmacy sector, the National Pharmacy Organisation (NPA) has called for a re-think on pharmacy representation vote, now scheduled to take place early next year.

The steering group responsible for the review of pharmacy representation in England had proposed to initiate a voting process later this year for the reform of the Pharmaceutical Services Negotiating Committee and Local Pharmaceutical Committees.


The Review Steering Group aims to hold a single vote to approve or reject the proposals for future contractor representation and support at both a national and local level. A two-thirds majority of all those casting a vote will be required to approve the vote.

The NPA says under these proposals there is a real possibility that a very small number of large pharmacy businesses could outvote thousands of independent community pharmacy contractors, virtually disenfranchising the entire sector.

“The voices of independent contractors must be properly heard in this process, by getting the explicit consent of the independent sector through a fair vote,” the pharmacy body adds.

The NPA suggests that an absolute majority of all eligible independent voters should approve any new structure, as well as an absolute majority of multiples, in addition to a two-thirds majority overall. This so-called ‘triple unlock’ is designed to ensure a cross-sector mandate for change.

NPA chair Andrew Lane said: “There’s a clear case for changing the way pharmacy contractors are represented in England, especially in the light of emerging NHS structures at local level. We need a system that works seamlessly from end to end – local to national.

“However, if change is to be sustainable and legitimate, it must be widely supported across community pharmacy. The Review Steering Group has said that it is seeking to build a consensus for change, yet the group’s proposed voting mechanism falls short of what is needed to guarantee a way forward that commands the support of the whole sector."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less